DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Lipocine Inc. (LPCN)
« Back to company indexLPCN Chatter Timeline
Stock Ticker for LPCN
Most Active Tweeters for LPCN
| User | Tweets |
|---|---|
| @Gambiste1 | 16 |
| @newsfilterio | 16 |
| @otcdynamics | 12 |
| @AmericanBanking | 7 |
| @ToothFrank | 6 |
Recent Tweets for LPCN
 |
@otcdynamics $LPCN ROSEN, A GLOBALLY RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Lipocine Inc. https://t.co/CreU5rMhWW November 19th 2019, 9:11pm |
|
@otcdynamics $LPCN SHAREHOLDER NOTICE: Scott+Scott Attorneys at Law LLP Investigates Lipocine Inc.’s Directors and Officers for B https://t.co/Mcvw28dBvA November 19th 2019, 9:11am |
 |
@Bernie96522561 Been seeing the $LPCN is getting the chance to resubmit, CEO buys 50K shares (Float increase), and two green days!… https://t.co/fAukQ2oXiv November 19th 2019, 9:11am |
 |
@1stOncology #Lipocine Announces Closing Of #PublicOffering Of #CommonStock And Warrants $LPCN https://t.co/2YtrqDfoS3 November 19th 2019, 8:11am |
 |
@ThisLincolnian Insider Buying: Lipocine Inc $LPCN CEO Buys 50,000 Shares of Stock https://t.co/ZU2ynlCKNd November 19th 2019, 5:11am |
 |
@WeekHerald Lipocine Inc $LPCN CEO Mahesh V. Patel Buys 50,000 Shares of Stock https://t.co/5wvhGA38pG November 19th 2019, 5:11am |
|
@dakotafinancial Lipocine $LPCN Stock Price Up 2.6% https://t.co/9WfFEm2WBQ November 19th 2019, 12:11am |
 |
@Gambiste1 RT @otcdynamics: $LPCN LIPOCINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against https://t.c… November 18th 2019, 11:11pm |
|
@otcdynamics $LPCN LIPOCINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against https://t.co/Sd0k8z4krS November 18th 2019, 9:11pm |
 |
@newsfilterio Form 424B5 (prospectus [rule 424(b)(5)]) filed with the SEC 3 days ago $LPCN https://t.co/1GpZe5qE72 November 18th 2019, 8:11pm |
|
@Gambiste1 RT @newsfilterio: Lipocine Announces Closing Of Public Offering Of Common Stock And Warrants $LPCN https://t.co/CTMLBlHVO6 November 18th 2019, 8:11pm |
|
@newsfilterio Lipocine Announces Closing Of Public Offering Of Common Stock And Warrants $LPCN https://t.co/CTMLBlHVO6 November 18th 2019, 7:11pm |
 |
@AmericanBanking Insider Buying: Lipocine Inc $LPCN CEO Buys 50,000 Shares of Stock https://t.co/boYymyS0Cu #stocks November 18th 2019, 6:11pm |
 |
@InsiderAlertsIA $LPCN: New Insider Filing on CEO and President MAHESH V. PATEL: https://t.co/R0Nbm73AaL November 18th 2019, 4:11pm |
|
@otcdynamics $LPCN Lipocine Announces Closing Of Public Offering Of Common Stock And Warrants https://t.co/cqkJsQSdoU November 18th 2019, 4:11pm |
|
@otcdynamics $LPCN SHAREHOLDER ALERT – Lipocine Inc. (LPCN) – Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Act https://t.co/R64h7UknOs November 18th 2019, 3:11pm |
 |
@TheMarketsDaily Brokerages Expect Lipocine Inc $LPCN Will Post Earnings of -$0.28 Per Share https://t.co/62GwJkH2rH November 18th 2019, 2:11pm |
|
@AmericanBanking Lipocine Inc $LPCN Expected to Announce Earnings of -$0.28 Per Share https://t.co/zD5WCVS1Jj #stocks November 18th 2019, 2:11pm |
 |
@newswithvalue $LPCN: LPCN INVESTOR ALERT: Bernstein Liebhard LLP Announces that …: https://t.co/whmAKAT5dS November 18th 2019, 12:11pm |
|
@otcdynamics $LPCN LPCN INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed https://t.co/cTxfKGq1P2 November 18th 2019, 12:11pm |
|
@otcdynamics $LPCN IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against https://t.co/LKsHSHM00R November 18th 2019, 10:11am |
 |
@vtcarguy81 $LPCN will they get another chance to argue their view that Cmax thresholds were set for transdermals and are not r… https://t.co/xpi0N8NQMR November 17th 2019, 1:11pm |
|
@Gambiste1 RT @newsfilterio: Form 424B5 (prospectus [rule 424(b)(5)]) filed with the SEC 3 days ago $LPCN https://t.co/e7VeLEPlg3 November 17th 2019, 4:11am |
|
@newsfilterio Form 424B5 (prospectus [rule 424(b)(5)]) filed with the SEC 3 days ago $LPCN https://t.co/e7VeLEPlg3 November 17th 2019, 2:11am |
 |
@scherfcom Weekly RECAP: Mon.(11/11): $LPCN plunged nearly -80%, then +50% rebound, then all-time lows. Tues.(11/12): $DPLO &… https://t.co/gm340FkVY0 November 16th 2019, 6:11pm |
|
@Gambiste1 RT @newsfilterio: Lipocine's Male Hormone Therapy Stumbles With FDA For The Third Time $LPCN https://t.co/xszTYjLTka November 16th 2019, 10:11am |
|
@Gambiste1 RT @newsfilterio: Lipocine Announces Pricing Of Public Offering Of Common Stock And Warrants $LPCN https://t.co/b9GQ1JEyER November 16th 2019, 10:11am |
|
@Gambiste1 RT @newsfilterio: Lipocine EPS beats by $0.11 $LPCN https://t.co/dVZrtZUlk0 November 16th 2019, 10:11am |
|
@newsfilterio Form 424B5 (prospectus [rule 424(b)(5)]) filed with the SEC 18 hours ago $LPCN https://t.co/1GpZe5qE72 November 16th 2019, 8:11am |
|
@Gambiste1 RT @newsfilterio: Lipocine Receives Complete Response Letter for TLANDO™ from U.S. FDA $LPCN https://t.co/LZ8GdLH5eU November 16th 2019, 4:11am |
|
@Gambiste1 RT @JosephRamelli: Had to unfollow somebody that posted a picture of handwritten notes on why $LPCN would get approval then tweeted after t… November 16th 2019, 1:11am |
 |
@JosephRamelli Had to unfollow somebody that posted a picture of handwritten notes on why $LPCN would get approval then tweeted af… https://t.co/xv9Rb8iTBn November 16th 2019, 12:11am |
|
@Gambiste1 RT @newsfilterio: Lipocine down 15% after hours on equity offering $LPCN https://t.co/P8vHuuXBlx November 15th 2019, 10:11pm |
 |
@ConsumerFeed Lipocine Inc $LPCN Short Interest Up 53.9% in October https://t.co/98v7UdkadA November 15th 2019, 9:11pm |
 |
@bbnsnews Lipocine Inc $LPCN Short Interest Up 53.9% in October https://t.co/XJIUDxWlxi November 15th 2019, 9:11pm |
|
@AmericanBanking Lipocine Inc $LPCN Short Interest Up 53.9% in October https://t.co/kJJaWpSW6e #stocks November 15th 2019, 9:11pm |
 |
@ResearchPool $LPCN #Lipocine Inc LPCN: Knocked Down But Not Knocked Out: | https://t.co/hFj3rjKAV2 #equity #stocks November 15th 2019, 8:11pm |
 |
@TickerReport Lipocine $LPCN Issues Earnings Results, Beats Estimates By $0.04 EPS https://t.co/BUrLdo4qaw November 15th 2019, 6:11pm |
 |
@dailypoliticaln Lipocine $LPCN Releases Earnings Results, Beats Estimates By $0.04 EPS https://t.co/9GBXGkmNV1 November 15th 2019, 6:11pm |
|
@otcdynamics $LPCN LIPOCINE DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 https://t.co/iOpLBVaJQV November 15th 2019, 5:11pm |
 |
@ProVesting $LPCN: IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces …: https://t.co/hG2vVW9Eh5 November 15th 2019, 2:11pm |
|
@otcdynamics $LPCN IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Lipocine https://t.co/t4XsYmI1Sl November 15th 2019, 1:11pm |
|
@otcdynamics $LPCN Pomerantz Law Firm Announces the Filing of a Class Action against Lipocine Inc. and Certain Officers – LPCN https://t.co/palcQp5zZ0 November 15th 2019, 1:11pm |
 |
@StockTexts $LPCN Pomerantz Law Firm Announces the Filing of a Class Action against Lipocine Inc. and Certain Officers – LPCN https://t.co/eZZoYmojxu November 15th 2019, 1:11pm |
 |
@cryptodude999 $LPCN When TA and FA cross roads, that's when it gets beautiful. https://t.co/UrEuDRvhB3 November 15th 2019, 1:11pm |
 |
@newswelldone $LPCN: EQUITY ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM …: https://t.co/EhNSOdWdUU November 15th 2019, 11:11am |
|
@otcdynamics $LPCN EQUITY ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit https://t.co/2q1KraGRkJ November 15th 2019, 10:11am |
|
@1stOncology #Lipocine Announces Pricing Of #PublicOffering Of Common Stock And Warrants $LPCN https://t.co/qjNI7Mlqoq November 15th 2019, 7:11am |
|
@1stOncology #Lipocine Announces Launch Of #PublicOffering Of #CommonStock And Warrants $LPCN https://t.co/z8QdPcTarJ November 15th 2019, 6:11am |
|
@ConsumerFeed HC Wainwright Cuts Lipocine $LPCN Price Target to $2.00 https://t.co/wuOmMswBW0 November 15th 2019, 5:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.